NFU1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.923800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.960200E-01
Normal-vs-Stage2
8.383400E-01
Normal-vs-Stage3
4.830400E-01
Normal-vs-Stage4
3.840000E-01
Stage1-vs-Stage2
7.846200E-01
Stage1-vs-Stage3
4.176400E-01
Stage1-vs-Stage4
4.073800E-01
Stage2-vs-Stage3
2.309600E-01
Stage2-vs-Stage4
3.190200E-01
Stage3-vs-Stage4
9.037400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.622000E-01
Normal-vs-AfricanAmerican
6.053800E-01
Normal-vs-Asian
5.574000E-01
Caucasian-vs-AfricanAmerican
4.549800E-01
Caucasian-vs-Asian
2.507000E-01
AfricanAmerican-vs-Asian
9.137400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.137000E-01
Normal-vs-Female
9.356800E-01
Male-vs-Female
4.684800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.234200E-01
Normal-vs-Age(41-60Yrs)
6.849000E-01
Normal-vs-Age(61-80Yrs)
8.660800E-01
Normal-vs-Age(81-100Yrs)
7.093000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.640400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.535600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.316600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.819700E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.909400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.250800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.668000E-01
Normal-vs-Daily Drinker
7.026000E-01
Normal-vs-Weekly Drinker
2.591800E-01
Normal-vs-Occasional Drinker
6.870400E-01
Normal-vs-Social Drinker
6.583800E-01
Non Drinker-vs-Daily Drinker
8.470000E-01
Non Drinker-vs-Weekly Drinker
2.377800E-01
Non Drinker-vs-Occasional Drinker
1.527570E-01
Non Drinker-vs-Social Drinker
1.066370E-01
Daily Drinker-vs-Weekly Drinker
1.646390E-01
Daily Drinker-vs-Occasional Drinker
1.838160E-01
Daily Drinker-vs-Social Drinker
1.351810E-01
Weekly Drinker-vs-Occasional Drinker
4.138200E-02
Weekly Drinker-vs-Social Drinker
1.185740E-02
Occasional Drinker-vs-Social Drinker
6.622200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.604970E-01
Normal-vs-Grade 2
7.997800E-03
Normal-vs-Grade 3
1.718320E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.981400E-01
Grade 1-vs-Grade 3
5.709800E-01
Grade 1-vs-Grade 4
1.604970E-01
Grade 2-vs-Grade 3
5.686000E-01
Grade 2-vs-Grade 4
7.997800E-03
Grade 3-vs-Grade 4
1.718320E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.785200E-01
Normal-vs-NonDiabetic
9.846600E-01
Diabetic-vs-NonDiabetic
6.237000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.752600E-01
Normal-vs-NoPancreatitis
9.632800E-01
Pancreatitis-vs-NoPancreatitis
6.264400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.372600E-01
Normal-vs-N1
8.934400E-01
N0-vs-N1
2.737400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.048200E-01
Normal-vs-TP53-NonMutant
9.673000E-01
TP53-Mutant-vs-TP53-NonMutant
4.212000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
